Search

Search Constraints

You searched for: Author/Creator Backman, Max

Search Results

1. ASCL1 promotes tumor progression through cell-autonomous signaling and immune modulation in a subset of lung adenocarcinoma. (1st October 2020)

2. Evaluation of NTRK immunohistochemistry as a screening method for NTRK gene fusion detection in non-small cell lung cancer. (January 2021)

3. FGFR1 overexpression in non-small cell lung cancer is mediated by genetic and epigenetic mechanisms and is a determinant of FGFR1 inhibitor response. (July 2021)

4. Fibroblast subsets in non-small cell lung cancer: Associations with survival, mutations, and immune features. (9th September 2022)

5. Infiltration of NK and plasma cells is associated with a distinct immune subset in non‐small cell lung cancer. Issue 3 (26th August 2021)

6. Multispectral imaging for quantitative and compartment‐specific immune infiltrates reveals distinct immune profiles that classify lung cancer patients. Issue 4 (5th February 2018)

8. Stromal FAP is an independent poor prognosis marker in non-small cell lung adenocarcinoma and associated with p53 mutation. (May 2021)